Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Potential Role of Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Ascites in Cirrhotic Patients

NCT05999773 is registered in ClinicalTrials.gov with University of Palermo as lead sponsor.

NCT NCT05999773
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05999773 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Potential Role of Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Ascites in Cirrhotic Patients
Lead sponsor
University of Palermo
Phase
Observational
Overall status
Active, not recruiting
Start date
July 15, 2023
Completion date
December 31, 2026
Enrollment
40 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

ascites hepatic, cirrhosis, liver, diabete type 2